Low income vs North Macedonia: Prevalence of hypertension
Low income
33.5%
in 2019
North Macedonia
45.1%
in 2019
Low income rank
25th
North Macedonia rank
24th
Prevalence of hypertension over time
- Low income
- North Macedonia
How they compare
North Macedonia currently reports 45.1% against 33.5% in Low income, a difference of 11.6%.
That makes North Macedonia's figure about 1.3 times Low income's.
Across all 30 years both countries report, North Macedonia has been ahead every year.
Low income ranks 25th and North Macedonia ranks 24th of 43 groups.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Low income | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 33.1% | 46.3% | 13.2% | North Macedonia |
| 2000s | 34.3% | 45.0% | 10.7% | North Macedonia |
| 2010s | 34.2% | 45.2% | 10.9% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, Low income or North Macedonia?
- North Macedonia, at 45.1% against 33.5% in Low income as of 2019.
- What is the difference in prevalence of hypertension between Low income and North Macedonia?
- 11.6%, with North Macedonia ahead.
- How many years of comparable data are there for Low income and North Macedonia?
- 30 years are reported by both, from 1990 to 2019.
- How do Low income and North Macedonia rank globally for prevalence of hypertension?
- Low income ranks 25th and North Macedonia ranks 24th of 43 groups.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension (% of adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension is the percentage of adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.